You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/5i72zzE4fno/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

New Lancet Study: Early COVID Treatment Prevented Clinical Deterioration

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 13:04 UTC on April 7th, 2024.

DrBeen Medical Lectures

DrBeen Medical

subscribers

BitChute Advertisement

New Lancet Study: Early COVID Treatment Prevented Clinical Deterioration

In this study from Lancet the researchers show a combination of drugs when started within 48 hours of mild COVID infection the likelihood of clinical deterioration is reduced …

New Lancet Study: Early COVID Treatment Prevented Clinical Deterioration

In this study from Lancet the researchers show a combination of drugs when started within 48 hours of mild COVID infection the likelihood of clinical deterioration is reduced significantly. Researchers write in their interpretation:

Interpretation
Early treatment with these combinations among outpatients diagnosed with COVID-19 was associated with lower likelihood of clinical deterioration, and with significant and rapid reduction in the viral load and serum cytokines, and with lower burden of PASC symptoms. When started very soon after symptom onset, these repurposed drugs have high potential to prevent clinical deterioration and death in vaccinated and unvaccinated COVID-19 patients.

Buy this T Shirt: My Monocytes Are Immortal. Ask Me Why!
https://drbeen-medical-lectures.creator-spring.com

If you like this content and want more, click here: https://www.drbeen.com/

Want to join my uncensored talks? Join me on patreon or substack:
Patreon: https://www.patreon.com/mobeensyed?fan_landing=true
Substack: https://mobeensyedmd.substack.com/

Want to support this work?:
BuyMeACoffee: https://www.buymeacoffee.com/drmobeensyed
PayPal: https://paypal.me/mobeensyed?locale.x=en_US

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

References:
DrBeen: Online Personalized Medical Education - DrBeen
https://www.drbeen.com/

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in ..

LESS